Bristol Myers Squibb Company ( BMY ) announced that it intends to seek FDA approval for its high potential immuno …read more
Bristol-Myers to Seek U.S. Approval for Immuno-Oncology Drug – Analyst Blog
- by Bob Mitchell
Bristol Myers Squibb Company ( BMY ) announced that it intends to seek FDA approval for its high potential immuno …read more